![]() |
|
To print: Select File and then Print from your browser's menu Title: Increased Serum Ferritin Common in Hypertensive Men |
| URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R Retrieve&db=PubMed&list_uids=12172312&dopt=Abstract |
|
J Hypertens 2002; 20:1513-1518. "Increased serum ferritin is common in men with essential hypertension." 08/21/2002 02:57:58 PM By Andrew A. Skolnick Increased serum ferritin, a possible risk factor for hepatic cirrhosis and atherogenesis, is common in hypertensive men. Alberto Piperno, at the University of Milan-Bicocca, Milan, Italy, and colleagues have found that men with essential hypertension may have a high prevalence of increased iron stores and metabolic abnormalities that are part of the insulin-resistance-associated hepatic iron overload syndrome (IRHIO). The investigators studied 88 consecutive patients with essential hypertension, 62 patients with IRHIO and 102 healthy normotensive controls. Patients with hemochromatosis, other conditions that may induce secondary iron overload, or serum ferritin increase unrelated to body iron stores were excluded. The researchers collected and analyzed the patients' iron indices, metabolic profiles, liver function and hepatic ultrasound data. They found that 21 percent of men with hypertension had increased serum ferritin, compared with none of the normotensive controls. Hypertensive men with increased serum ferritin had more frequent and pronounced metabolic alterations than those with normal serum ferritin. The metabolic abnormalities and serum ferritin were frequently positively correlated, the researchers reported. They also found that the metabollic and iron data in hypertensive men with increased serum ferritin were similar to those of IRHIO patients with Hypertension. "In males, hypertension is characterized by a higher prevalence of increased iron stores and metabolic abnormalities that are part of the IRHIO syndrome," the researchers concluded. "This finding may have clinical implications due to the increased risk of IRHIO patients to develop hepatic cirrhosis and also for the role of iron in early atherogenesis." |
| http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=R Retrieve&db=PubMed&list_uids=12172312&dopt=Abstract |
|
Copyright © 2009 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. Go back This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 2009 P\S\L Consulting Group Inc. All rights reserved. |